Neurocrine Bioscience buy Jefferies Financial Group Inc.
Start price
19.08.24
/
50%
€133.70
Target price
19.08.25
€170.67
Performance (%)
-15.48%
End price
20.08.25
€113.00
Summary
This prediction ended on 20.08.25 with a price of €113.00. The prediction for Neurocrine Bioscience disappointed with a performance of -15.48%. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 2.294% | 2.294% | 39.185% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Jefferies_Financial_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Jefferies Financial Group Inc. from $177.00 to $189.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten